Abstract
Xeroderma pigmentosum is a rare autosomal recessive genodermatosis caused by a defect in nucleotide excision repair. The disease is characterized by increased skin sensitivity after minimal sun exposure. These patients are born with normal appearing skin but develop dermatological changes between the first and second year of life. Xerodermia pigmentosum presents with changes in skin pigmentation in a freckle-like distribution. In addition, patients will present with poikiloderma, xerosis, skin atrophy, lentigines, actinic keratosis and telangiectasias. The main complications of the disease are premalignant and malignant skin lesions. The most common cause of death is metastatic melanoma or invasive squamous cell carcinoma.
Xeroderma pigmentosum is also associated with ophthalmological, neurodegenerative and endocrine disorders.
There is no curative treatment; management is based on early diagnosis of the disease through the detection of biallelic mutations and the implementation of early protective measures to reduce complications and mortality.
Keywords
References
Rizza ERH, DiGiovanna JJ, Khan SG, Tamura D, Jeskey JD, Kraemer KH. Xeroderma pigmentosum: A model for human premature aging. J Invest Dermatol [Internet]. 2021;141(4):976–84. DOI: http://dx.doi.org/10.1016/j.jid.2020.11.012
Piccione M, Belloni Fortina A, Ferri G, Andolina G, Beretta L, Cividini A, et al. Xeroderma Pigmentosum: General aspects and management. J Pers Med [Internet]. 2021;11(11):1146. DOI: http://dx.doi.org/10.3390/jpm11111146
Black JO. Xeroderma pigmentosum. Head Neck Pathol [Internet]. 2016;10(2):139–44. DOI: http://dx.doi.org/10.1007/s12105-016-0707-8
Brambullo T, Colonna MR, Vindigni V, Piaserico S, Masciopinto G, Galeano M, et al. Xeroderma pigmentosum: A genetic condition skin cancer correlated—A systematic review. Biomed Res Int [Internet]. 2022;2022:1–12. DOI: http://dx.doi.org/10.1155/2022/8549532
Leung AKC, Barankin B, Lam JM, Leong KF, Hon KL. Xeroderma pigmentosum: an updated review. Drugs Context [Internet]. 2022;11:1–17. DOI: http://dx.doi.org/10.7573/dic.2022-2-5
Merideth M, Tamura D, Angra D, Khan SG, Ferrell J, Goldstein AM, et al. Reproductive health in xeroderma pigmentosum: Features of premature aging. Obstet Gynecol [Internet]. 2019;134(4):814–9. DOI: http://dx.doi.org/10.1097/aog.0000000000003490
Nasrallah NA, Wiese BM, Sears CR. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies. Front Oncol [Internet]. 2022;12. DOI: http://dx.doi.org/10.3389/fonc.2022.846965
Schierbeck J, Vestergaard T, Bygum A. Skin cancer associated genodermatoses: A literature review. Acta Derm Venereol [Internet]. 2019;99(4):360–9. DOI: http://dx.doi.org/10.2340/00015555-3123
Lehmann AR, Fassihi H. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum. DNA Repair (Amst) [Internet]. 2020;93(102907):102907. DOI: http://dx.doi.org/10.1016/j.dnarep.2020.102907
Abeti R, Zeitlberger A, Peelo C, Fassihi H, Sarkany RPE, Lehmann AR, et al. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms. Br J Pharmacol [Internet]. 2019;176(22):4293–301. DOI: http://dx.doi.org/10.1111/bph.14557
De Andrade FAG, Cavalcanti CE de O, Isoldi FC, Ferreira LM. Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review. Indian J Dermatol Venereol Leprol [Internet]. 2021;87(176):176–89. DOI: http://dx.doi.org/10.25259/ijdvl_431_19
Baykal C, Atcı T, Yılmaz Z, Büyükbabani N. Skin tumors in xeroderma pigmentosum: Evaluation of a large series and a literature review. J Cutan Pathol [Internet]. 2021;48(7):884–95. DOI: http://dx.doi.org/10.1111/cup.13979
Fischer S, Hamed M, Emmert S, Wolkenhauer O, Fuellen G, Thiem A. The prognostic and predictive role of xeroderma pigmentosum gene expression in melanoma. Front Oncol [Internet]. 2022;12. DOI: http://dx.doi.org/10.3389/fonc.2022.810058
Nikolaev S, Yurchenko AA, Sarasin A. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts. Orphanet J Rare Dis [Internet]. 2022;17(1). DOI: http://dx.doi.org/10.1186/s13023-022-02203-1
Cazar Melo DC, Armas Vega ADC. Etiología más frecuente del cáncer oral en adultos jóvenes: una revisión de literatura [Internet]. 2022 [citado el 14 de julio, 2024]. DOI: http://dx.doi.org/10.36097/rsan.v0i52.2149
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2024 Array